Published in TB and Outbreaks Week, July 12th, 2011
"In view of this, antiviral approaches with novel mechanisms of action are required to combat resistant influenza strains. Objectives Our study aimed to determine the toxic concentrations of the newly synthesized compounds...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.